期刊文献+

T管套U管治疗不能手术切除的肝门部胆管癌 被引量:4

A T Tube Sheathed U Tube Approach for Unresectable HilarCholangiocarcinoma
下载PDF
导出
摘要 [目的]探讨用一简便、有效、并发症相对少的方法治疗不能手术切除的肝门部胆管癌。[方法]采用自行设计的T管套U管的引流方法治疗不能手术切除的肝门部胆管癌24例,与同期我们用传统的胆肠吻合+U管引流的方法治疗41例相比较。[结果]T管套U管组手术时间为45min、手术并发症有3例(12.5%)、术后胆道感染3例(12.5%)。吻合组手术时间为145min,手术并发症有17例(41%),术后胆道感染16例(39%)。该3项指标前者明显优于后者。手术后退黄、手术死亡、中位生存期两组无明显差异。[结论]T管套U管手术引流治疗不能手术切除的肝门部胆管癌,手术简单,手术后并发症少,术后胆道感染机会低。 [ Objective ] To evaluate the effectiveness of T-tube sheathed U-tube approach for unre-sectable hilar cholangiocarcinoma. [Methods] T-tube sheathed U-tube for unresectable hilar cholan-giocarcinoma were employed in 24 cases form 1991 to 2001. The clinical data were collected and compared with 41 cases of traditional T-tube drainage plus bilio-jejunal anastomosis. [Results] Compared with the group of tranditional anastomosis , patients in the group of T-tube sheathed U-tube had significant shorter mean operation time(45 min vs 145 min, P < 0. 05), decreased morbidility rate (12. 5% vs 41%, P < 0. 05) and fewer chances of postoperative biliary tract infection (12. 5% vs 39%, P < 0. 05). However, there were no signicant differences between these two groups in mortality rate(4. 2% vs 9.8% , P> 0. 05) and survival time(8 months vs 7.2 months, P> 0. 05) . [Conclusion] T-tube sheathed U-tube approach for unresectable hilar cholangiocarcinoma is a simple procesure, with decreased morbidity and fewer chances of postoperative biliary tract infection.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2003年第4期395-397,共3页 Journal of Sun Yat-Sen University:Medical Sciences
基金 中山医科大学科研基金(2001003)
关键词 肝门部胆管癌 T管 U管 引流手术 术后胆道感染 cholangiocarcinoma /surgery internal drainage U tube T tube
  • 相关文献

参考文献5

二级参考文献9

共引文献163

同被引文献13

  • 1陈伟,简志祥,林叶,区金锐,侯宝华,郑江华.肝门部胆管癌的预后因素分析——附67例报告[J].新医学,2005,36(6):323-325. 被引量:1
  • 2Miziumoto R, Kawarada Y, Suzuk H. Surgical treatment of hilar carcinoma of the bile duct[J] .Surg Gynecol Obstetm, 1996,162(2): 153. 被引量:1
  • 3Jamgin WR, Fong Y,De Matteo R, et al. Staging, resectability, and outcome in 225 patients with cholangiocarcinoma [ J ]. Ann Surg, 2001,234(4) :507 - 519. 被引量:1
  • 4Chandhmy PM, Robinson lB. Induction MDRI (p-glycopro- tein) gene expression in human cells byprotein kinase C agonist [J].Oned Res, 1992,4(3) : 281. 被引量:1
  • 5Bismuth H, Nakaehe R, Dimntmd T. Management strategies in resection for hilar eholangiocareinoma[J]. Ann Surg, 1992,215 (1):31. 被引量:1
  • 6Nimura Y, Hayakawi N, Kamiya J", et al. Hepatectamy for Har bile duet cancer[J]. Asian J Stag, 1996,19 : 94. 被引量:1
  • 7Stroszczynski C, Hunerbein M. Malignant biliary obstruction: value of imaging findings[J].Abdom Imaging, 2005, 30 (3): 314-323. 被引量:1
  • 8Pichlmays R, Weiman A, Klenlanaster J, et al. Surgical trealr- nent in proximal bile duet cancer. A sinde center experience[J]. Ann Surg, 1996,224(5):628. 被引量:1
  • 9Iwatsuki S, Todo S, Marsh JW, et al. Treatment 0f hilar cholangiocarci noma (Klatskin tumors)with hepatic reflection or transplantation[J].J Am Coll, 1998,187 (4) : 358. 被引量:1
  • 10周宁新,黄志强,冯玉泉,顾万清,蔡守旺,张文智,黄晓强,段云鹏,王敬,纪文斌.肝门部胆管癌103例外科治疗远期疗效的评析[J].中华外科杂志,1997,35(11):649-653. 被引量:110

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部